T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation

Nature Medicine

Volumn 9, Issue 10, 2003, Pages 1318-1322

  Brewer, Judson A ^a   Khor, Bernard ^a   Vogt, Sherri K ^a   Muglia, Lisa M ^a   Fujiwara, Hideji ^b   Haegele, Karen E ^a   Sleckman, Barry P ^a   Muglia, Louis J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; CYCLOOXYGENASE 2; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LETHALITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIGENS, CD3; CECUM; CYCLOOXYGENASE 2; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM; ISOENZYMES; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

ANIMALIA;

EID: 0142137222     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm895     Document Type: Article

References (25)

1. Webster, J.I., Tonelli, L. & Sternberg, E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20, 125-163 (2002).
2. Bertini, R., Bianchi, M. & Ghezzi, P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1708-1712 (1988).
3. Winoto, A. & Littman, D.R. Nuclear hormone receptors in T lymphocytes. Cell 109, S57-S66 (2002).
4. Ashwell, J.D., Vacchio, M.S. & Galon, J, Do glucocorticoids participate in thymocyte development? Immunol. Today 21, 644-646 (2000).
5. Jondal, M., Pazirandeh, A. & Okret, S. A role for glucocorticoids in the thymus? Trends Immunol. 22, 185-186 (2001).
6. King, L.B. et al. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3, 647-656 (1995).
7. Purton, J.F., Boyd, R.L., Cole, T.J. & Godfrey, D.I. Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 13, 179-186 (2000).
8. Cole, T.J, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Gen. Dev. 9, 1608-1621 (1995).
9. Da Silva, J.A. Sex hormones and glucocorticoids: interactions with the immune system. Ann. N. Y. Acad. Sci, 876, 102-117 (1999).
10. Vacchio, M,S., Lee, J.Y. & Ashwell, J.D. Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation. J. Immunol. 163, 1327-1333 (1999).
11. Scott, D.E., Gause, W.C., Finkelman, F.D. & Steinberg, A.D. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J. Immunol. 145, 2183-2188 (1990).
12. Charpentier, B. et al. Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome. Transplantation 54, 997-1002 (1992).
13. Ferran, C. et al. Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids. Transplantation 50, 642-648 (1990).
14. Franchimont, D. et al. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J. Immunol. 164, 1768-1774 (2000).
15. Iniguez, M.A., Punzon, C. & Fresno, M. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J. Immunol. 163, 111-119 (1999).
16. Gross, G. et al. Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R1415-R1423 (2000).
17. Penning, T.D. et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J. Med. Chem. 40, 1347-1365 (1997).
18. Li, H., Llera, A., Malchiodi, E.L. & Mariuzza, R.A. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 17, 435-466 (1999).
19. Tanaka, K. et al. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J. Immunol. 164, 2277-2280 (2000).
20. Merger, M. et al. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut 51, 155-163 (2002).
21. +-ATPase. J. Clin. Invest. 110, 1739-1747 (2002).
22. Bethin, K.E., Vogt, S.K. & Muglia, L.J. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. USA 97, 9317-9322 (2000).
23. Muglia, L.J., Jenkins, N.A., Gilbert, D.J., Copeland, N.G. & Maizoub, J.A. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J. Clin. Invest. 93, 2066-2072 (1994).
24. Muglia, L.J. et al. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J. Clin. Invest. 105, 1269-1277 (2000).
25. Ferran, C. et al. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway. Eur. J. Immunol. 21, 2349-2353 (1991).